| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | Eran Broshy | Director | Nov 26, 2025 | Sale | $20.00 | 29,501 | 590,020 | 60,204 | Dec 01, 2025, 07:02 PM | |
| TBPH | Theravance Biopharma, Inc. | Eran Broshy | Director | Nov 11, 2025 | Sale | $17.98 | 45,000 | 809,250 | 75,704 | Nov 14, 2025, 06:00 AM | |
| TBPH | Theravance Biopharma, Inc. | Eran Broshy | Director | Nov 11, 2025 | Sale | $18.11 | 59,000 | 1,068,250 | 61,704 | Nov 13, 2025, 09:00 PM | |
| CERT | Certara, Inc. | Eran Broshy | Director | May 21, 2025 | Option/RSU Exercise | - | 11,928 | - | 34,951 | May 22, 2025, 04:58 PM | |
| CERT | Certara, Inc. | Eran Broshy | Director | May 21, 2024 | Option/RSU Exercise | - | 8,663 | - | 23,023 | May 23, 2024, 04:17 PM | |
| CERT | Certara, Inc. | Eran Broshy | Director | Aug 22, 2023 | Buy | $15.80 | 4,807 | 75,951 | 14,360 | Aug 23, 2023, 04:38 PM | |
| CERT | Certara, Inc. | Eran Broshy | Director | Aug 21, 2023 | Buy | $16.10 | 193 | 3,107 | 9,553 | Aug 23, 2023, 04:38 PM | |
| CERT | Certara, Inc. | Eran Broshy | Director | May 23, 2023 | Option/RSU Exercise | - | 9,360 | - | 9,360 | May 25, 2023, 08:50 AM |
